Evaluating the functional aspects of genetic variation in prostate cancer would advance our understanding of its aetiology and enable population stratification for screening. Eeles et al. provide an overview of the current evidence on the germline genetic variants in prostate cancer development, as well as the association of these variants with clinical outcomes.
- Rosalind Eeles
- Chee Goh
- Zsofia Kote-Jarai
